Business
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION WALTHAM, Mass. and DUBLIN, Ireland, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA) (“Mural”) today announced that its shareholders have voted to approve the previously announced proposed acquisition of Mural by XRA 5 Corp. (“Sub”), a wholly owned subsidiary of XOMA Royalty Cor
About this update from Xoma Royalty Corporation
[{"type":"image","alt":"Mural Oncology plc","displaySize":"","headline":null,"caption":"Mural Oncology plc","className":"","disableSlideshowImg":false,"size":{"original":{"width":88,"height":88,"url":"https://media.zenfs.com/en/globenewswire.com/1b6663b6201f735e2c2128546a473e12"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/trDKv_LKo1IPQavaIPFv5g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTExMDtoPTExMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/1b6663b6201f735e2c2128546a473e12","width":88,"height":88}},"lazy":false},{"type":"text","content":"NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION ","length":201,"tagName":"p"},{"type":"text","content":"WALTHAM, Mass. and DUBLIN, Ireland, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA) (“Mural”) today announced that its shareholders have voted to approve the previously announced proposed acquisition of Mural by XRA 5 Corp. (“Sub”), a wholly owned subsidiary of XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA Royalty”). As described in more detail below, a majority in number of the shareholders of record present and voting, either in person or by proxy and more than 99 percent of the votes cast at both a scheme meeting of shareholders (the “Scheme Meeting”) and an extraordinary general meeting of shareholders (the “EGM”), both held on October 24, 2025 in Dublin, Ireland, were in favour of the transaction, representing in respect of the Scheme Meeting, approximately 58 percent of the shares outstanding and eligible to be voted at the Scheme Meeting and in respect of the EGM, approximately 61 percent of the shares outstanding and eligible to be voted at the EGM.","length":1002,"tagName":"p"},{"type":"text","content":"Under the terms of the transaction agreement among XOMA Royalty, Sub and Mural announced on August 20, 2025 (the “Transaction Agreement”), Sub has agreed to acquire the entire issued and to be issued share capital of Mural (the “Acquisition”). Under the terms of the Acquisition and subject to certain conditions, following closing, each Mural shareholder (i) would receive a base cash price of $2.035 per share (the “Base Price Per Share”), which has been calculated on the basis of Mural having approximately $36.2 million...